Table 3

Immunostaining results of other markers studied.

ECA

EMMA

p-value


ER

Score 0–3

11/14 (79%)

1/18 (6%)

<0.001

Score 4–12

3/14 (21%)

17/18 (94%)

Median (Range)

0 (0–12)

7.5 (2–12)

<0.001

PR

Score 0–3

11/14 (79%)

2/18 (11%)

<0.001

Score 4–12

3/14 (21%)

16/18 (89%)

Median (Range)

0 (0–12)

9 (1–12)

<0.001

Vim

Score 0–3

13/14 (93%)

9/18 (50%)

0.01

Score 4–12

1/14 (7%)

9/18 (50%)

Median (Range)

0 (0–2)

1.5 (0–9)

0.002


ECA, endocervical adenocarcinoma; EMMA, endometrial mucinous adenocarcinoma; NS, not significant.

Khoury et al. BMC Clinical Pathology 2006 6:1   doi:10.1186/1472-6890-6-1

Open Data